What we do
The European Medical Journal (EMJ) is an open-access, peer-reviewed medical publisher serving more than one million healthcare professionals around the world, with journals spanning 18 therapeutic areas:
- Allergy & Immunology
- Cardiology
- Dermatology
- Diabetes
- Gastroenterology
- Hematology
- Hepatology
- Innovations
- Interventional Cardiology
- Microbiology & Infectious Diseases
- Nephrology
- Neurology
- Oncology
- Radiology
- Reproductive Health
- Respiratory
- Rheumatology
- Urology
Who we are
Founded in 2012, EMJ was established with a clear vision: to elevate the quality of healthcare globally by keeping busy healthcare professionals informed about the latest advances in medicine.
Today, we deliver high-quality medical education for our loyal community of HCPs through our expert-led journals, award-recognised podcasts, innovative patient case studies, and industry-leading interactive content. We also cater to the pharmaceutical sector through EMJ GOLD, our dedicated resource for life sciences professionals.
In 2024, we expanded our reach with the launch of the American Medical Journal (AMJ), extending our offering to HCPs and industry partners in the United States.
In 2025, we became an EBAC-accredited provider of Continuing Medical Education (CME) through EMJ Learning, our professional development platform delivering high-quality educational content for HCPs.
Our goal and mission
Across all of our brands, our goal is to become the go-to place for healthcare and pharma professionals worldwide by 2030, while building trust between these two communities in healthcare.
To get there, we hold ourselves to a high standard across everything we publish, supported by a dedicated in-house publishing team, expert Editorial Boards and our unique EQOH score, which measures how our content influences clinical practice.
Our mission is to create Gold Medal Winners in everything we do, from our teams across three countries to our readers and listeners around the world. In 2026, we were voted one of the ‘Sunday Times Best Places to Work’ in the UK.
How we work with industry
Alongside our independent editorial output, we work with trusted industry partners to share the latest advances from leading medical congresses and beyond.
What sets us apart is that we share congress coverage within six weeks of an event, ensuring the swift dissemination of insights to the wider healthcare community.
Where to find us
EMJ is headquartered in London, UK, with additional offices in Miami, USA and Amsterdam, the Netherlands.
Senior Leadership Team
Spencer Gore
Founder and Chairman
Dan Healy
Chief Commerical Officer
Justin Levett
Chief Executive Officer
Justin Burnett
Chief Financial Officer
Professor Jonathan Sackier
Chairman, Medical Advisory Board